Charles Elliott Sigal Vir Biotechnology, Inc. (VIR) insider trading activity

VIR Quotes by TradingView

Charles Elliott Sigal is Director of Vir Biotechnology, Inc.. Currently has a direct ownership of 23,806 shares of VIR, which is worth approximately $159,500. The most recent transaction as insider was on May 30, 2024, when has been sold 8,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.8K
0% 3M change
50.61% 12M change
Total Value Held $159,500

Charles Elliott Sigal Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 30 2024
BUY
Grant, award, or other acquisition
-
8,000 Added 25.15%
23,806 Common Stock
May 22 2023
BUY
Grant, award, or other acquisition
-
6,027 Added 27.61%
15,806 Common Stock
May 23 2022
BUY
Grant, award, or other acquisition
-
6,405 Added 39.58%
9,779 Common Stock
May 21 2021
BUY
Grant, award, or other acquisition
-
3,374 Added 50.0%
3,374 Common Stock

Also insider at

SURF
Surface Oncology, Inc. Healthcare
Director
ADAP
Adaptimmune Therapeutics PLC Healthcare
Director
ALNY
ALNYLAM PHARMACEUTICALS, INC. Healthcare
Director
CES

Charles Elliott Sigal

Director
Cambridge, MA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if
Any

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Vir Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIR